|
1
|
Smyth EC, Lagergren J, Fitzgerald RC,
Lordick F, Shah MA, Lagergren P and Cunningham D: Oesophageal
cancer. Nat Rev Dis Prim. 3:170482017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Murphy G, McCormack V, Abedi-Ardekani B,
Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC,
Fleischer DE, et al: International cancer seminars: A focus on
esophageal squamous cell carcinoma. Ann Oncol. 28:2086–2093. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Borggreve AS, Kingma BF, Domrachev SA,
Koshkin MA, Ruurda JP, van Hillegersberg R, Takeda FR and Goense L:
Surgical treatment of esophageal cancer in the era of multimodality
management. Ann N Y Acad Sci. 1434:192–209. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saeki H, Nakashima Y, Zaitsu Y, Tsuda Y,
Kasagi Y, Ando K, Imamura Y, Ohgaki K, Ito S, Kimura Y, et al:
Current status of and perspectives regarding neoadjuvant
chemoradiotherapy for locally advanced esophageal squamous cell
carcinoma. Surg Today. 46:261–267. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Workum F, Berkelmans GH, Klarenbeek
BR, Nieuwenhuijzen GAP, Luyer MDP and Rosman C: McKeown or Ivor
Lewis totally minimally invasive esophagectomy for cancer of the
esophagus and gastroesophageal junction: Systematic review and
meta-analysis. J Thorac Dis. 9 (Suppl 8):S826–S833. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yibulayin W, Abulizi S, Lv H and Sun W:
Minimally invasive oesophagectomy versus open esophagectomy for
resectable esophageal cancer: A meta-analysis. World J Surg Oncol.
14:3042016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kurakin AV, Wu S and Bredesen DE: Atypical
recognition consensus of CIN85/SETA/Ruk SH3 domains revealed by
target-assisted iterative screening. J Biol Chem. 278:34102–34109.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kowanetz K, Husnjak K, Höller D, Kowanetz
M, Soubeyran P, Hirsch D, Schmidt MHH, Pavelic K, De Camilli P,
Randazzo PA, et al: CIN85 associates with multiple effectors
controlling intracellular trafficking of epidermal growth factor
receptors. Mol Biol Cell. 15:3155–3166. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Havrylov S, Redowicz MJ and Buchman VL:
Emerging roles of Ruk/CIN85 in vesicle-mediated transport,
adhesion, migration and malignancy. Traffic. 11:721–731. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gout I, Middleton G, Adu J, Ninkina NN,
Drobot LB, Filonenko V, Matsuka G, Davies AM, Waterfield M and
Buchman VL: Negative regulation of PI 3-kinase by Ruk, a novel
adaptor protein. EMBO J. 19:4015–4025. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cascio S and Finn OJ: Complex of MUC1,
CIN85 and Cbl in colon cancer progression and metastasis. Cancers
(Basel). 7:342–352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wakasaki T, Masuda M, Niiro H,
Jabbarzadeh-Tabrizi S, Noda K, Taniyama T, Komune S and Akashi K: A
critical role of c-Cbl-interacting protein of 85 kDa in the
development and progression of head and neck squamous cell
carcinomas through the ras-ERK pathway. Neoplasia. 12:789–796.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cascio S, Farkas AM, Hughey RP and Finn
OJ: Altered glycosylation of MUC1 influences its association with
CIN85: The role of this novel complex in cancer cell invasion and
migration. Oncotarget. 4:1686–1697. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rice TW, Ishwaran H, Hofstetter WL, Kelsen
DP, Apperson-Hansen C and Blackstone EH; Worldwide Esophageal
Cancer Collaboration Investigators, : Recommendations for
pathologic staging (pTNM) of cancer of the esophagus and
esophagogastric junction for the 8th edition AJCC/UICC staging
manuals. Dis Esophagus. 29:897–905. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Camacho Londoño J and Philipp SE: A
reliable method for quantification of splice variants using
RT-qPCR. BMC Mol Biol. 17:82016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hnasko TS and Hnasko RM: The Western Blot.
Methods Mol Biol. 1318:87–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jeong DY, Lee KS, Choi JY, Chung MJ, Min
YW, Kim HK, Zo JI, Shim YM and Sun JM: Surgically Resected
Esophageal Squamous Cell Carcinoma: Patient Survival and
Clinicopathological Prognostic Factors. Sci Rep. 10:50772020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Q, Wang F, Lv J, Xin J, Xie L, Zhu W,
Tang Y, Li Y, Zhao X, Wang Y, et al: Interactive online consensus
survival tool for esophageal squamous cell carcinoma prognosis
analysis. Oncol Lett. 18:1199–1206. 2019.PubMed/NCBI
|
|
19
|
Jiang D, Li X, Wang H, Shi Y, Xu C, Lu S,
Huang J, Xu Y, Zeng H, Su J, Hou Y and Tan L: The prognostic value
of EGFR overexpression and amplification in Esophageal squamous
cell Carcinoma. BMC Cancer. 15:3772015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo N, Zhao LC, Shi QQ, Feng ZQ, Chen DL
and Li J: Induction of Apoptosis in Human Leukemic Cell Lines by
Diallyl Disulfide via Modulation of EGFR/ERK/PKM2 Signaling
Pathways. Asian Pac J Cancer Prev. 16:3509–3515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Take H, Watanabe S, Takeda K, Yu ZX, Iwata
N and Kajigaya S: Cloning and characterization of a novel adaptor
protein, CIN85, that interacts with c-Cbl. Biochem Biophys Res
Commun. 268:321–328. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Watanabe S, Take H, Takeda K, Yu ZX, Iwata
N and Kajigaya S: Characterization of the CIN85 adaptor protein and
identification of components involved in CIN85 complexes. Biochem
Biophys Res Commun. 278:167–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Niiro H, Jabbarzadeh-Tabrizi S, Kikushige
Y, Shima T, Noda K, Ota S, Tsuzuki H, Inoue Y, Arinobu Y, Iwasaki
H, et al: CIN85 is required for Cbl-mediated regulation of antigen
receptor signaling in human B cells. Blood. 119:2263–2273. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brett TJ1, Traub LM and Fremont DH:
Accessory protein recruitment motifs in clathrin-mediated
endocytosis. Structure. 10:797–809. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Legendre-Guillemin V, Wasiak S, Hussain
NK, Angers A and McPherson PS: ENTH/ANTH proteins and
clathrin-mediated membrane budding. J Cell Sci. 117:9–18. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Donaldson JG and Jackson CL: ARF family G
proteins and their regulators: Roles in membrane transport,
development and disease. Nat Rev Mol Cell Biol. 12:362–375. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lanier MH, McConnell P and Cooper JA: Cell
Migration and Invadopodia Formation Require a Membrane-binding
Domain of CARMIL2. J Biol Chem. 291:1076–1091. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nam JM, Onodera Y, Mazaki Y, Miyoshi H,
Hashimoto S and Sabe H: CIN85, a Cbl-interacting protein, is a
component of AMAP1-mediated breast cancer invasion machinery. EMBO
J. 26:647–656. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lito P, Mets BD, Kleff S, O'Reilly S,
Maher VM and McCormick JJ: Evidence that sprouty 2 is necessary for
sarcoma formation by H-Ras oncogene-transformed human fibroblasts.
J Biol Chem. 283:2002–2009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Samoylenko A, Vynnytska-Myronovska B, Byts
N, Kozlova N, Basaraba O, Pasichnyk G, Palyvoda K, Bobak Y, Barska
M, Mayevska O, et al: Increased levels of the HER1 adaptor protein
Rukl/CIN85 contribute to breast cancer malignancy. Carcinogenesis.
33:1976–1984. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bögler O, Furnari FB, Kindler-Roehrborn A,
Sykes VW, Yung R, Huang HJ and Cavenee WK: SETA: A novel SH3
domain-containing adapter molecule associated with malignancy in
astrocytes. Neuro-oncol. 2:6–15. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hashimoto S, Hirose M, Hashimoto A,
Morishige M, Yamada A, Hosaka H, Akagi K, Ogawa E, Oneyama C,
Agatsuma T, et al: Targeting AMAP1 and cortactin binding bearing an
atypical src homology 3/proline interface for prevention of breast
cancer invasion and metastasis. Proc Natl Acad Sci USA.
103:7036–7041. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sato S, Zhao Y, Imai M, Simister PC,
Feller SM, Trackman PC, Kirsch KH and Sonenshein GE: Inhibition of
CIN85-mediated invasion by a novel SH3 domain binding motif in the
lysyl oxidase propeptide. PLoS One. 8:772882013. View Article : Google Scholar
|
